Abstract
Polyarteritis nodosa (PAN) primarily affects medium-sized arteries that supply the skin, gut, nerve, and kidney. However, multiple other organs can be involved either clinically or subclinically. Microaneurysms of arteries to or within the kidneys, liver, or gastrointestinal tract are highly characteristic of PAN. Mononeuritis multiplex, an asymmetric sensory and motor neuropathy due to ischemia and infarction of peripheral nerves, occurs frequently in PAN. In mononeuritis multiplex, nerve conduction studies of peripheral nerves reveal a distal, asymmetric, axonal neuropathy involving both motor and sensory nerves. PAN is characterized pathologically by patchy, trans-mural inflammation in medium- and small-sized muscular arteries, sparing large arteries, capillaries, and the venous system. The inflammation leads to fibrinoid necrosis, but is not associated with granulomatous features. High-dose glucocorticoids are the mainstay of therapy in PAN. In cases that are rapidly progressive or life or organ threatening, however, cyclophosphamide is added to glucocorticoid treatment.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Arepally GM, Ortel TL. Heparin-induced thrombocytopenia. N Engl J Med. 2006;355:809–17
Bazari H, Jaff MR, Mannstadt M, Yan S. Case 7-2007: a 59 year-old woman with diabetic renal disease and nonhealing skin ulcers. N Engl J Med. 2007; 356:1049–57
Callen JP. Livedoid vasculopathy: what it is and how the patient should be evaluated and treated. Arch Dermatol. 2006;142:1481–2
Coffman TM, Crowley SD. Kidney in hypertension: Guyton redux. Hypertension 2008;51:811–16
Collins MP, Mendell JR, Periquet MI, et al Superficial peroneal nerve/ peroneus brevis muscle biopsy in vasculitic neuropathy. Neurology 2000;55:636–43
Ehrmann S. Ein Gefaessprozess Bei Lues. Wien Med Wochenschr. 1907;57:777
Frances C, Niang S, Laffitte E, et al Dermatologic manifestations of the antiphospholipid syndrome. Arthritis Rheum. 2005;52: 1785–93
Frances C, Piette JC. The mystery of Sneddon's syndrome: the relationship with antiphospholipid syndrome and systemic lupus erythema-tosus. J Autoimmun. 2000;15:139–43
Frances C, Papo T, Wechser B, et al Sneddon's syndrome with and without aPL. Medicine 1999;78:209–19
Gorson KC, Hedley-White ET, Skinner MM. Case records of the Massachusetts General Hospital. N Eng J Med. 2001;344: 917–23
Guillevin L, Lhote F. Treatment of polyarteritis nodosa and microscopic polyangiitis. Arthritis Rheum. 1998;41:2100–5
Guillevin L, Cohen P, Mahr A, et al Treatment of polyarteritis nodosa and microscopic polyangiitis with poor prognosis factors: a prospective trial comparing glucocorticoids and six or twelve cyclo-phosphamide pulses in sixty-five patients. Arthritis Rheum. 2003; 49:93–100
Ha C, Nousari, HC. Double trephine punch biopsy technique for sampling subcutaneous tissue. J Am Acad Dermatol. 2003;48:609–10
Hairston BR, Davis MD, Pittelkow MR, Ahmed I. Livedoid vasculopa-thy: further evidence for procoagulant pathogenesis. Arch Dermatol. 2006;142:1413–8
Kroshinsky D, Stone JH, Bloch D, Sepehr A. A 47 year-old woman with numbness and pain in the lower extremities. N Engl J Med. 2009; 360:711–20
Kussmaul A, Maier R. Über eine bisher nicht beschriebene eigenthum-liche arterienerkrankung (periarteritis nodosa), die mit morbus brightii und rapid fortschreitender allgemeiner muskellahmung ein-hergeht. Dtsch Arch Klin Med. 1866;1:484–518
London NJ, Donnelly R. ABC of arterial and venous disease: ulcerated lower limb. BMJ 2000;320:1589–91
Maessen-Visch M, Koedam M, Hamulyak K, et al Atrophie blanche. Int J Dermatol. 1999;38:161–72
Mathew L, Talbot K, Love S, et al Treatment of vasculitic peripheral neuropathy: a retrospective analysis of outcome. QJM 2007; 100:41–57
Matsumoto T, Homma S, Okada M, et al The lung in polyarteritis nodosa: a pathologic study of 10 cases. Hum Pathol. 1993;24:717–24
Mimouni D, Ng PP, Rencic A, et al Cutaneous PAN in patients presenting with atrophie blanche. Br J Dermatol. 2003;148:789–94
Pagnoux C, Seror R, Mahr A, et al Polyarteritis nodosa: clinical description and long-term follow-up of the 351 patients from the French Vasculitis Study Group. Arthritis Rheum. 2006;49:S420
Stockhammer GJ, Felber SR, Zelger B, et al Sneddon's syndrome: diagnosis by skin biopsy and MRI in 17 patients. Stroke 1993;24:685–90
Stone JH, Talor M, Stebbing J, et al Test characteristics of immunofluo-rescence and ELISA tests in 856 consecutive patients with possible ANCA-associated conditions. Arthritis Care Res. 2000;13: 424–34
Stone JH, Nousari HC. “Essential” cutaneous vasculitis: what every rheumatologist should know about vasculitis of the skin. Curr Opin Rheumatol. 2001;13:23–34
Talor M V, Stone JH, Stebbing JJ, et al Antibodies to selected minor target antigens in patients with anti-neutrophil cytoplasmic antibodies (ANCA) by immunofluorescence antibodies to minor target antigens in patients with anti-neutrophil cytoplasmic antibodies. Clin Exp Immunol. 2007;150:42–8
Uthman IW, Khamashta MA. Livedo racemosa: a striking dermatological sign for the antiphospholipid syndrome. J Rheumatol. 2006;33: 2379–82
Vallat J-M, Cros DP, Hedley-White ET. Case 9-2007: a 27 year-old woman with pain and swelling of the legs. N Engl J Med. 2007;356: 1252–9
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Springer Science+Business Media B.V.
About this chapter
Cite this chapter
Stone, J.H. (2009). Polyarteritis Nodosa. In: Stone, J.H. (eds) A Clinician's Pearls and Myths in Rheumatology. Springer, London. https://doi.org/10.1007/978-1-84800-934-9_26
Download citation
DOI: https://doi.org/10.1007/978-1-84800-934-9_26
Publisher Name: Springer, London
Print ISBN: 978-1-84800-933-2
Online ISBN: 978-1-84800-934-9
eBook Packages: MedicineMedicine (R0)